Hannah L. Kalvin

Memorial Sloan Kettering Cancer Center

Papers

1

Total Citations

2

H-Index

1

About

Hannah L. Kalvin is a surgical oncologist whose research centers on advanced minimally invasive techniques for hepatobiliary and pancreatic malignancies, with a particular focus on hepatic artery infusion pump (HAIP) chemotherapy. Her most-cited work, "Robotic Versus Open Placement of Hepatic Artery Infusion Pumps" (2025), addresses a critical gap in the literature by systematically comparing outcomes between robotic and open approaches for HAIP placement. This study demonstrates her commitment to refining surgical methods that expand treatment access for patients with advanced liver tumors. While her citation count is still emerging, her work is already shaping practice at major cancer centers adopting robotic platforms. Dr. Kalvin’s research is notable for its emphasis on perioperative outcomes and technical feasibility, providing evidence that robotic HAIP placement can achieve comparable safety and efficacy to traditional open surgery. Her contributions are particularly valuable for surgeons seeking to integrate robotic techniques into complex oncologic procedures, and her ongoing work promises to further define the role of minimally invasive surgery in liver-directed therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Versus Open Placement of Hepatic Artery Infusion Pumps
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago